Everside and Marathon agree to merge

Denver-based Everside Health and Marathon Health, headquartered in Indianapolis, have announced the closing of a merger that will see the two entities combine to serve patients in health centers across 41 states.

Specializing in advanced primary care and occupational health for employer and union-sponsored clients, the two provider groups have a combined 680 health centers and serve 2.5 million patients. Going forward, all will operate under the Marathon Health banner, with Jeff Wells, MD, current Marathon Health CEO, and Ben Evans, current Marathon Health Executive Chairman, continuing in their roles. Chris Miller, current Everside Health CEO, is departing his role but will remain a significant shareholder of the new business.

“The merger of Marathon Health and Everside Health will create a stronger combined organization even better equipped to build a primary care model designed with patient experience and outcomes in mind,” Wells says in a news release. “With projected annual healthcare costs for a family of four soaring to over $31,000 in 2023, much-needed primary, occupational and mental health care services are out of reach for most Americans.”

Marathon Health uses a value-based care model that it says can lower employer and union partner healthcare costs by more than 25%. Both Marathon and Everside have received industry accolades in recent years, with Marathon getting the 2024 “Best in KLAS” award for employer sponsored health services and Everside receiving that designation in 2022.

The integration of Marathon Health and Everside Health is expected to be completed within the next 12 months.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup